Department of Pediatrics and Child Health, Aga Khan University, Karachi, Pakistan.
Department of Biological & Biomedical Sciences, Aga Khan University, Karachi, Pakistan.
PLoS One. 2019 Aug 23;14(8):e0221095. doi: 10.1371/journal.pone.0221095. eCollection 2019.
Environmental Enteric Dysfunction (EED) is an acquired small intestinal inflammatory condition underlying high rates of stunting in children <5 years of age in low- and middle-income countries. Children with EED are known to have repeated exposures to enteropathogens and environmental toxins that leads to malabsorptive syndrome. We aimed to characterize association of linear growth faltering with enteropathogen burden and subsequent changes in EED biomarkers. In a longitudinal birth cohort (n = 272), monthly anthropometric measurements (Length for Age Z score- LAZ) of asymptomatic children were obtained up to 18 months. Biological samples were collected at 6 and 9 months for the assessment of biomarkers. A customized TaqMan array card was used to target 40 enteropathogens in fecal samples. Linear regression was applied to study the effect of specific enteropathogen infection on change in linear growth (ΔLAZ). Presence of any pathogen in fecal sample correlated with serum flagellin IgA (6 mo, r = 0.19, p = 0.002), fecal Reg 1b (6 mo, r = 0.16, p = 0.01; 9mo, r = 0.16, p = 0.008) and serum Reg 1b (6 mo, r = 0.26, p<0.0001; 9 mo, r = 0.15, p = 0.008). At 6 months, presence of Campylobacter [β (SE) 7751.2 (2608.5), p = 0.003] and ETEC LT [β (SE) 7089.2 (3015.04), p = 0.019] was associated with increase in MPO. Giardia was associated with increase in Reg1b [β (SE) 72.189 (26.394), p = 0.006] and anti-flic IgA[β (SE) 0.054 (0.021), p = 0.0091]. Multiple enteropathogen infections in early life negatively correlated with ΔLAZ, and simultaneous changes in gut inflammatory and permeability markers. A combination vaccine targeting enteropathogens in early life could help in the prevention of future stunting.
环境肠道功能障碍 (EED) 是一种获得性小肠炎症状态,是导致低收入和中等收入国家 5 岁以下儿童生长迟缓率高的原因。已知患有 EED 的儿童会反复接触肠病原体和环境毒素,从而导致吸收不良综合征。我们旨在描述线性生长迟缓与肠病原体负担及随后 EED 生物标志物变化之间的关联。在一项纵向出生队列研究中(n=272),对无症状儿童进行每月一次的人体测量(年龄别身长 Z 评分-LAZ),最长持续到 18 个月。在 6 个月和 9 个月时采集生物样本,以评估生物标志物。使用定制的 TaqMan 微阵列卡靶向粪便样本中的 40 种肠病原体。线性回归用于研究特定肠病原体感染对线性生长变化(ΔLAZ)的影响。粪便样本中任何病原体的存在均与血清鞭毛蛋白 IgA(6 个月,r=0.19,p=0.002)、粪便 Reg1b(6 个月,r=0.16,p=0.01;9 个月,r=0.16,p=0.008)和血清 Reg1b(6 个月,r=0.26,p<0.0001;9 个月,r=0.15,p=0.008)呈正相关。6 个月时,空肠弯曲菌(β(SE)7751.2(2608.5),p=0.003)和肠产毒性大肠埃希菌 LT(β(SE)7089.2(3015.04),p=0.019)的存在与 MPO 增加有关。贾第虫与 Reg1b 增加有关(β(SE)72.189(26.394),p=0.006)和抗 flic IgA 增加有关(β(SE)0.054(0.021),p=0.0091)。生命早期的多种肠病原体感染与 ΔLAZ 呈负相关,同时与肠道炎症和通透性标志物的变化相关。针对生命早期肠病原体的联合疫苗可能有助于预防未来的生长迟缓。